Kolexia
Huvent-Grelle Dominique
Gériatrie
Usld Les Bateliers Chu Lille
Lille, France
43 Activités
34 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladie d'Alzheimer Démence COVID-19 Maladies neurodégénératives Démence vasculaire Fragilité Infections à coronavirus Troubles de l'endormissement et du maintien du sommeil Dystonie

Industries

A+A
12 collaboration(s)
Dernière en 2023
Novartis
3 collaboration(s)
Dernière en 2023
Pfizer
3 collaboration(s)
Dernière en 2021
PASCALEO
2 collaboration(s)
Dernière en 2023

Dernières activités

Medication exposure of the dyad patient-caregiver in Alzheimer's disease and related dementias: a cross-sectional study.
International journal of clinical pharmacy   02 août 2023
Impact of pharmaceutical care integrated at a psychosocial intervention to reduce caregiver's burden in Alzheimer's disease or related dementias: Negative results at 18 months and difficulties to conduct PHARMAID RCT.
Contemporary clinical trials communications   22 avril 2023
The effect of the severity of neurocognitive disorders on emotional and motor responses to music.
Annals of the New York Academy of Sciences   02 novembre 2022
Hypnosis Intervention for Couples Confronted with Alzheimer's Disease: Promising Results of a First Exploratory Study.
Journal of Alzheimer's disease : JAD   18 octobre 2022
Serum neutralization of SARS coronavirus 2 Omicron sublineages BA.1 and BA.2 and cellular immune responses 3 months after booster vaccination.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases   17 octobre 2022
Immunogenicity of BNT162b2 vaccine booster against SARS-CoV-2 Delta and Omicron variants in nursing home residents: A prospective observational study in older adults aged from 68 to 98 years.
The Lancet regional health. Europe   21 avril 2022
Sensorimotor Synchronization in Healthy Aging and Neurocognitive Disorders.
Frontiers in psychology   17 mars 2022
CAFCA: Multicentre, Randomized, Double-blind, Placebo-controlled Trial Evaluating the Effect of a 30-week Caffeine Treatment on Cognition in Alzheimer's Disease at Beginning to Moderate Stages
Essai Clinique (CHU Lille)   10 février 2022
Impaired Functional T-Cell Response to SARS-CoV-2 After Two Doses of BNT162b2 mRNA Vaccine in Older People.
Frontiers in immunology   16 novembre 2021
Does a Live Performance Impact Synchronization to Musical Rhythm in Cognitively Impaired Elderly?
Journal of Alzheimer's disease : JAD   27 septembre 2021